Story thread · 2 reports / 2 sources
MindRank Partners with 3SBio to Commercialize its AI-Designed Oral GLP-1 in China
thestar.com · 4h · first report
HANGZHOU, China, Sept. 28, 2026 (GLOBE NEWSWIRE) -- MindRank AI Ltd. ("MindRank") today announced that it has entered into a strategic commercialization agreement with Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd. ("Mandi") and Zhejiang Wansheng Pharmaceutical Co., Ltd. ("Wansheng"), both subsidiaries…
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.